SML1630

Bendazac

≥98% (HPLC)

• Synonym(s): Bendazolic acid, [(1-Benzyl-1H-indazol-3-yl)oxy]acetic acid
• Empirical Formula (Hill Notation): C₁₆H₁₄N₂O₃
• CAS Number: 20187-55-7
• Molecular Weight: 282.29
• NACRES: NA.77
• PubChem Substance ID: 329825514
• UNSPSC Code: 12352200
• EC Number: 243-569-2
• MDL number: MFCD00866158
• Assay: ≥98% (HPLC)
• Form: powder
• Quality level: 200

Properties

• InChI key: BYFMCKSPFYVMOU-UHFFFAOYSA-N
• InChI: 1S/C16H14N2O3/c19-15(20)11-21-16-13-8-4-5-9-14(13)18(17-16)10-12-6-2-1-3-7-12/h1-9H,10-11H2,(H,19,20)
• SMILES string: OC(COC1=NN(CC2=CC=CC=C2)C3=CC=CC=C31)=O
• assay: ≥98% (HPLC)
• form: powder
• solubility: DMSO: soluble ≥1 mg/mL, methanol: soluble ≥1 mg/mL
• storage temp.: 2-8°C
• Quality Level: 200
• Gene Information: human ... XDH(7498)

Description

Biochem/physiol Actions

Bendazac (or bendazolic acid) is a non-steroidal anti-inflammatory drug used for joint and muscular pain. Bendazac is an anti-denaturant drug for cataract and other condensation diseases. In addition, Bendazac has been used in studies related to potential treatment and pevention of ischemia and reperfusion syndromes, and was found to inhibit only reversible and irreversible xanthine oxidase.

Bendazac is a non-steroidal anti-inflammatory drug used for joint and muscular pain.

Safety Information

• Storage Class: 11 - Combustible Solids
• wgk: WGK 3